RFA-OH-23-002: Occupational Safety and Health Surveillance Collaboration, Education, and Translation (U24)
Closed
This grant is closed. A newer notice from the same program is open now: Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) (RFA-OH-26-015). Status: Closes December 8, 2026 (31 days left). It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2022.
Centers for Disease Control and Prevention - ERA offered grants of up to $275,000 (at least $100,000) to any type of organization. It expected to make one award worth $1.4 million in total. Applications closed on January 13, 2023.
From the official notice on Grants.gov, last changed October 12, 2022. Checked November 7, 2026.
- Award ceiling$275,000
- Award floor$100,000
- Total funding$1.4 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | October 12, 2022 |
|---|---|
| Deadline | January 13, 2023 |
| Archived by Grants.gov | January 18, 2028 |
Who can apply
This opportunity was open to any type of organization.
All 16 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
See Section III. Eligibility Information.
Is this a realistic fit?
- Past Occupational Safety and Health Program awards averaged $1.9 million; this notice allows up to $275,000 per award.
- No cost sharing or match is required.
What the grant funds
The Centers for Disease Control and Prevention (CDC) National Institute for Occupational Safety and Health (NIOSH) seeks applications to promote national collaboration, education, and translation to strengthen capacity building for occupational safety and health (OSH) surveillance and associated activities. The recipient funded under this Notice of Funding Opportunity (NOFO) will use research and/or non-research approaches to enhance collaboration among federal, state, tribal, local, and territorial jurisdictions currently funded by NIOSH to implement OSH programs, and facilitate the participation in OSH surveillance programs and associated activities by jurisdictions not currently supported under NIOSH state surveillance grants. The funded recipient is expected to: Lead national level coordination and collaboration of OSH surveillance and communications in partnership with federal state, tribal, local, and territorial agencies. Support the development and growth of state, tribal, local, territorial, and non-governmental (NGO) partnerships to use and promote surveillance research to practice.
Who has won Occupational Safety and Health Program grants before
From fiscal 2021 to 2025, Occupational Safety and Health Program (93.262) awarded $590 million across 305 grant awards, an average of $1.9 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| City of New York | New York | 1 | $39.5 million |
| CPWR: the Center for Construction Research and Training | Maryland | 2 | $27.2 million |
| The University of Iowa | Iowa | 5 | $23.6 million |
| University of Illinois | Illinois | 5 | $21.2 million |
| Icahn School of Medicine at Mount Sinai | New York | 16 | $18.9 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, RFA-OH-26-015, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-OH-23-002 still open?
No. It closed on January 13, 2023. A newer notice is open: RFA-OH-26-015, closes December 8, 2026 (31 days left).
Who can apply for Occupational Safety and Health Surveillance Collaboration, Education, and Translation (U24)?
Centers for Disease Control and Prevention - ERA accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Occupational Safety and Health Surveillance Collaboration, Education, and Translation (U24)?
Closed January 13, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $275,000 each. About $1.4 million in total for one award.
Who has won Occupational Safety and Health Program grants before?
The largest recipients over five fiscal years were City of New York, CPWR: the Center for Construction Research and Training, The University of Iowa. The program made 305 awards worth $590 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)